Glenn Tabolt

Associate Director, Bioanalytical Development at Apogee Therapeutics

Glenn Tabolt is an experienced professional in the field of bioanalysis, currently serving as Associate Director at Dermavant Sciences since July 2018, where responsibilities include coordinating bioanalytical activities and providing regulatory guidance for nonclinical and clinical programs. Prior to this role, Glenn held positions at Roivant Sciences, managing bioanalytical support across projects, and at Covance as Lead Scientist, focusing on method development and validation. Earlier experience includes roles at GSK, where oversight of bioanalytical assays was a key responsibility, and at Cardinal Health, where responsibilities included method validation and sample analysis. Glenn holds a Master's degree in Secondary Science Education and a Bachelor's degree in Chemistry from the State University of New York College at Potsdam.

Links

Previous companies

Roivant Sciences logo